Not Yet Recruiting
NA
INTERVENTIONAL
NCT06873425
Research on the Improvement of Intestinal and Immune Functions by Probiotics
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
Evaluate the effectiveness and safety of Limosilactobacillus fermentum LF61 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.
Interventions
Name:
Probiotic
Type:
DIETARY_SUPPLEMENT
Description:
Dietary supplement: Probiotics. The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).
Name:
Placebo
Type:
DIETARY_SUPPLEMENT
Description:
Dietary supplement: Placebo. The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).
Primary Outcomes
Measure:
Change of concentration of antimicrobial peptide LL-37
TimeFrame:
Week 0 and Week 8
Description:
Detected by Enzyme-Linked Immunosorbent Assay (ELISA).
Measure:
Change in calcarein concentration
TimeFrame:
Week 0 and Week 8
Description:
Detected by Enzyme-Linked Immunosorbent Assay (ELISA).
Trial Information
NCT ID
NCT06873425
Status
Not Yet Recruiting
Study Type
INTERVENTIONAL
Phases
NA
Sponsor
Wecare Probiotics Co., Ltd.
Last Updated
December 15, 2025